Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

N Engl J Med. 2016 Jun 23;374(25):2497-8. doi: 10.1056/NEJMc1603180.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Single-Domain Antibodies / therapeutic use*
  • von Willebrand Factor / antagonists & inhibitors*

Substances

  • Fibrinolytic Agents
  • Single-Domain Antibodies
  • von Willebrand Factor